Corvus Pharmaceuticals, Inc.
SEC CIK 1626971 · CRVS · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Clark IAN T | Director | filed 2017 - 2026 |
| Thompson Peter A. | Director | filed 2016 - 2026 |
| Grais Linda S | Director | filed 2019 - 2026 |
| van den Broek Richard | Director | filed 2025 - 2026 |
| Moore David Scott | Director | filed 2025 - 2026 |
| Miller Richard A MD | Director · President and CEO | filed 2016 - 2026 |
| Chan Andrew C. | Director | filed 2026 - 2026 |
| Orbimed Advisors LLC | Director | filed 2016 - 2025 |
| Orbimed Capital GP V LLC | Director | filed 2016 - 2025 |
| Morrison Scott W | Director | filed 2016 - 2025 |
| Gould Terry P | Director | filed 2016 - 2024 |
| Mitchell Edith P. | Director | filed 2020 - 2023 |
| Krognes Steve E. | Director | filed 2016 - 2020 |
| Isaly Samuel D | Director | filed 2016 - 2016 |
| Moldt Peter | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jones William Benton | VP Pharmaceutical Development | filed 2016 - 2025 |
| Arcara Jeffrey | Chief Business Officer | filed 2024 - 2025 |
| LEA Leiv | Chief Financial Officer | filed 2016 - 2025 |
| Mobasher Mehrdad | VP, Chief Medical Officer | filed 2019 - 2020 |
| Buggy Joseph J | EVP, Discovery Research | filed 2018 - 2019 |
| Verner Erik J. | VP, Chemistry Research | filed 2016 - 2019 |
| Hunt Daniel W. | SVP, Chief Business Officer | filed 2017 - 2019 |
| Coloma Jason V | SVP, Chief Business Officer | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.